FDA Grants Theradaptive Breakthrough Medical Device Designation

Theradaptive Logo
Published on :

Theradaptive, a privately held biopharmaceutical company pioneering a new class of regenerative implants announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Medical Device designation to its Osteo-Adapt SP Spinal Fusion implant indicated for transforaminal lumbar interbody spinal fusion to treat degenerative disc disease, spondylolisthesis, or retrolisthesis.

Nine Veteran-Owned Life Science Companies to Know in the BioHealth Capital Region

Six BioHealth Capital Region Veteran-Owned Life Science Companies to Know
Published on :

On this Veteran’s Day 2020, we celebrate BHCR veteran-owned life science companies that you should keep an eye on as we head into 2021.

Industry Leaders Identify Key Growth Factors for Cell and Gene Therapy Market

Published on :

At Maryland Lifesciences’ 2020 Bio Innovation Conference, American Gene Technologies (AGT) took center stage. AGT was the virtual event’s diamond sponsor, AGT’s CEO and Founder Jeff Galvin kicked off the event with opening remarks and then hosted several panel discussions, including “Expanding Progress and Opportunities in Gene and Cell Therapy,” which was a highlight of the conference’s second day.